Skip to content
thestock.space

iSERA Lifesciences (BSE: ISERA) is loss-making over the last 12 months, losing ₹0.06 Cr, so a P/E ratio does not apply. Its share price on 6 Nov 2026 was ₹143.90. Debt is 0.20× equity. It is a small-cap company with a market cap of ₹354 Cr, ranked 62nd of 126 Information Technology Services companies by market cap; the shares rose 1701% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹143.90
Day high
₹143.90
Day low
₹143.90
Prev. close
₹143.90
Volume
50

Health check

1 good · 4 to check
  • ReturnsAhead

    +1701.0% over a year, better than 7 of 7 peers.

  • Price tagLoss-making

    Earnings were negative over the last 12 months.

  • Growthn/a

    Not enough yearly results to measure.

  • ProfitabilityWeak

    ROCE 3.4% vs peer median 27.2%.

  • Balance sheetStretched

    Debt 0.20× equity, Piotroski 2 of 9.

  • Red flags2 to check

    Loss-making over the last twelve months.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Information Technology Services

125 listed peers. Screen the industry

Small cap

₹354 Cr, #62 of 126 in its industry by size.

Defensive

Beta 0.39 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹1 Cr · profit ₹−0 Cr
Market cap
₹354 Cr
Small cap
P/E
n/a
Industry 17.7
Price to book
14.67
Peers 5.20
Dividend yield
0.00%
ROE
6.4%
Peers 22.9%
ROCE
3.4%
Peers 27.2%
Debt to equity
0.20
Debt ₹1.66 Cr
EPS (TTM)
−₹1.82
OPM (TTM)
−3.0%
Net margin −4.5%
Sales growth
n/a
Year-ago quarter not reported
Profit growth
n/a
Year-ago quarter not reported
Price to sales
261.16

Strengths and risks

Risks to check

  • Loss-making over the last twelve months.
  • Return on equity is low at 6.4%.

No standout strengths in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About iSERA Lifesciences

iSERA Lifesciences Limited engages in the IT/ITES business in India. It also offers web-based solutions, data processing, back-office processing, accounting and payroll processing, data warehousing, database management, consultancy, outsourcing, as well as staffing and other technology enabled services. The company was formerly known as Covidh Technologies Limited and changed its name to iSERA Lifesciences Limited in April 2026. iSERA Lifesciences Limited…

Headquarters
Pune
Sector
Technology
ISIN
INE899M01020

Price range

52 weeks

₹8.30₹151.05

Today

₹143.90₹143.90
Avg volume (3M)
787
1-year return
plus 1701.0%
From 52-week high
minus 4.7%

Peers · Information Technology Services

Company
TCSTata Consultancy Services2,498.50plus 0.11%9,03,97917.57.6054.9%45.6%26.5%5.8%5.3%1.92%minus 16.5%
INFYInfosys1,181.40plus 1.20%4,78,51115.74.9139.0%30.0%23.1%6.7%6.9%4.40%minus 20.5%
HCLTECHHCL Technologies1,440.00plus 0.66%3,89,75421.35.2027.2%24.6%20.8%8.7%3.9%3.33%minus 6.4%
WIPROWipro198.00minus 0.20%1,95,89815.62.4617.8%15.9%19.2%0.8%5.2%4.04%minus 16.6%
TECHMTech Mahindra1,831.00plus 0.46%1,79,47629.45.4719.8%19.2%17.2%2.2%−0.1%2.79%plus 29.3%
LTMLTM4,338.00minus 1.25%1,28,62024.64.9725.4%21.0%17.9%8.4%4.4%1.80%minus 21.8%
PERSISTENTPersistent Systems6,053.50minus 0.92%99,85953.011.1229.4%22.9%16.9%20.9%26.5%0.59%plus 4.3%
ISERAiSERA Lifesciences143.900.00%354–14.673.4%6.4%−3.0%––0.00%plus 1701.0%
Median of 7 peers–0.11%1,95,89821.35.2027.2%22.9%19.2%6.7%5.2%2.79%−16.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
––0.21.2–
––0.50.6–
−00−0.30.6−0.3
––−146.0%49.0%–
0000.10
−00−0.30.6−0.3
–––12.3%–
−00−0.30.5−0.3
-0.050.22-2.021.58-1.60

Profit & loss

Yearly, ₹ crore
ROE
6.4%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
––0.31.4
––0.11.1
−0.1−0.10.10.3
––52.4%19.6%
−0000.1
0−0––
−0.1−0.10.10.3
––15.0%22.9%
−0.1−0.10.10.3
-1241.84-3.143.650.74

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
0.30.30.38.4
−0.4−0.5−0.4−0.2
0.10.21.61.7
00.100.7
0.10.11.610.6
–––5
0002.9
00.11.52.7
0.10.11.610.6

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−0.1−0.1−1.4−5.4
–––0.1
0.10.11.48.1
0−002.8
−0.1−0.1−1.4−5.4

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders. Institutions hold about 1.7% (Yahoo estimate).

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you